A family with familial amyloid polyneuropathy (FAP) due to a transthyretin (TTR) Leu58Arg mutation was investigated clinicopathologically. The proband presented with sensori-motor-autonomic polyneuropathy, and autopsy demonstrated massive amyloid deposition in the peripheral nerves and heart. However, the mother was characterized by carpal tunnel syndrome and ocular vitreous opacities. Thus, there was considerable phenotypic heterogeneity among family members despite the identical TTR genotype. Motozaki et al. page 4 
Introduction
Familial amyloid polyneuropathy (FAP) is a disorder with autosomal dominant inheritance caused by a mutant transthyretin. The clinical features include neurologic and non-neurologic manifestations such as sensorimotor polyneuropathy, autonomic dysfunction, carpal tunnel syndrome (CTS), cardiomyopathy, renal dysfunction, gastrointestinal dysfunction, endocrine dysfunction, vitreous opacity, and glaucoma.
Major foci of FAP are located in Japan, Portugal, and Sweden [1] . In those areas, a TTR Val30Met mutation is most common cause [1] ; patients with the Val30Met mutation usually present with sensory dominant polyneuropathy, autonomic failure, rhythm and conduction disturbances of heart, and renal failure. Recently, more than 100 single or double mutations and a deletion in the TTR gene have been reported to be associated with FAP [1] .
In 1991, a new mutation causing TTR, Leu58Arg, was reported in a family in Kanazawa, Japan [2] . However, clinical and pathologic features associated with this mutation have not been studied. There have not been any reports of other FAP families with the Leu58Arg mutation. We here describe, for the first time, clinicopathologic Motozaki et al. page 5 features of the Japanese FAP kindred with a Leu58Arg TTR mutation. Thereafter, both the polyneuropathic and autonomic symptoms slowly progressed.
Case reports

Patient 1 (V-I).
He developed orthostatic syncope at age 42. At age 43, the patient suddenly developed cardiopulmonary arrest, and died of pneumonia three weeks after. The total duration of his illness was 9 years. Autopsy was performed 2.5 hours after death.
Histopathological and immunohistochemical studies of the autopsied tissues demonstrated deposition of TTR-positive amyloid in systemic organs and tissues in various degrees (Table 1, Fig. 2 ). The heart weighed 550 g, showing cardiomegaly with massive amyloid deposition in the endo-and myocardium ( Fig. 2A) .
Prominent amyloid deposition was found in the peripheral nervous system including the sciatic nerves (Fig. 2B) . In the central nervous system, massive amyloid deposition Motozaki et al. page 7 was observed in the dura mater (Fig. 2F) , in addition to mild amyloid deposition in the leptomeningeal vessels, subpial brain parenchyma (Fig. 2G) , and choroid plexus.
Besides the amyloid deposition, acute ischemic changes in the brain and purulent bronchopneumonia were observed.
Patient 2 (IV-2).
The patient was the mother of Patient 1. She complained of muscle weakness and dysesthesia in the right thumb at age 47. Two month later, she also developed muscle weakness and dysesthesia in the left thumb. She was diagnosed as having bilateral CTS. She received local injection of corticosteroid and surgical treatment for the CTS. Thereafter, however, her symptoms gradually progressed. At age 53, she developed visual disturbance due to the vitreous opacities. Neurological examination at age 62 demonstrated complete blindness in the right eye, blurred vision in the left eye, and reduced sense of touch, pain, and temperature and weakness of the hands due to the CTS. The TTR Leu58Arg mutation was also detected [2] .
Discussion
Motozaki et al. A variety of clinicopathologic phenotypes have been reported in association with a variety of TTR mutations. CTS is the main feature of the disorder that was formerly called FAP type II, Rukavina [3] or Maryland type [4] . Maryland type FAP was reported to be related to a TTR Leu58His mutation [5] [6] [7] . Interestingly, this mutation is at the same site as the mutation found in our patients, but differed in the substituted amino acid.
In addition to CTS, the clinical features of FAP with the TTR Leu58His mutation include progressive sensori-motor polyneuropathy, and cardiomyopathy or nephropathy in the advanced stage of the disease or at autopsy [4] . Onset with CTS and slowly progressive course in our Patient 2 with the Leu58Arg mutation resembled the features of FAP with the Leu58His mutation. However, vitreous opacities as found in our Patient 2 are rare, and Motozaki et al. page 9 polyneuropathy with initial motor involvement as found in our Patient 1 has not been previously reported in FAP with the Leu58His mutation [4] [5] [6] [7] [8] . It is reported that different TTR mutants are associated with differences in the efficiency of the endoplasmic machinery that targets destabilized mutant proteins for degradation and the enhanced tendency of these variants to aggregate if secreted, which may lead to different tissue selective amyloid diseases [9] . The phenotypic difference of FAP between the Leu58His and Leu58Arg mutations suggest differences in the secretion efficiency or aggregation characteristics of the TTR variants, despite the same mutation site, as the difference is found between TTR Val30Met and Val30Gly mutations [9] .
Different phenotypes between the affected family members despite the identical TTR genotype in this family would indicate that factors other than the mutant TTR influence the pathogenesis of FAP due to the Leu58Arg mutation, as suggested in FAP due to other mutations [10] . These factors would include environmental as well as the other genetic components, requiring further study. 
